Trial Profile
An Open-label Pilot Study of Delayed Mycophenolate Mofetil Instead of Tacrolimus Combined With Anti-thymocyte Globulin, Daclizumab, Etanercept, and Sirolimus in Single-donor, Solitary Islet Allograft Recipients With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Antithymocyte globulin; Daclizumab; Sirolimus
- Indications Islet cell transplant rejection
- Focus Adverse reactions; Pharmacodynamics
- 28 Dec 2009 New trial record